etanercept

Key facts

INN

etanercept

Brand

ENBREL

Route

SUBCUTANEOUS

Formulation

VIAL

Related patents

patent

US 11419812

Methods for delivering etanercept preparations into a lumen of the intestinal tr

Expires Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11135267

Etanercept formulations stabilized with metal ions

Expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11129876

Etanercept formulations stabilized with amino acids

Expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11000588

Etanercept formulations stabilized with sodium chloride

Expires Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11001627

Correctly folded etanercept in high purity and excellent yield

Expires Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 10987405

Method of reducing formation of etanercept aggregates or fragments

Expires Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 10980885

Method of reducing formation of etanercept aggregates or fragments

Expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 10980884

Stable aqueous etanercept composition

Expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

Related news

NewsHeart FailureApr 7, 2026

FDA Priority Review Granted to CardioGen's RevivCor for Heart Failure

CardioGen's RevivCor has received FDA Priority Review status for heart failure, signaling a potential breakthrough in treatment options for patients.

Dr. Sarah Mitchell

Frequently asked questions

What is etanercept?

etanercept (ENBREL), is a pharmaceutical active ingredient, with approved status in the US.

What is the brand name for etanercept?

ENBREL is a marketed brand name for etanercept. Check FDA Drugs@FDA for the current US label holder.